Stock Analysts

Synthetic Biologics Unveils Top-Line Safety Data on SYN-004

Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into the commercial potential of the candidate once it is successfully developed and commercialized. Early last week, Synthetic Biologics, Inc […]

Stock Analysts

Mechel’s Trade Port Posiet Achieves Record Coal Cargo

Russian miner Mechel OAO ( MTL ) recently announced that the Trade Port Posiet has attained 5 million tons of annual cargo volume of coal products by Dec 25. This was by far the best cargo report in the port’s history. Coal shipment with 5-millionth tonne of coal was dispatched to the People's Republic of China […]

Stock Analysts

Novartis’ Cosentyx Approved in Japan for Psoriatic Arthritis

Novartis ( NVS ) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Cosentyx (secukinumab) for the treatment of both psoriasis vulgaris and psoriatic arthritis (PsA) in adults who have failed to respond adequately to systemic therapies (except for biologics). The approval was based on positive safety and efficacy results from more than 10 phase II and phase III studies and supported by two pivotal phase III studies, FUTURE 1 and FUTURE 2. The studies demonstrated a favorable safety profile for Cosentyx, with similar incidence and severity of adverse events across the different treatment arms. […]

Stock Analysts

Toyota Production Up 1.4% YTD, Down 6.6% in November

Toyota Motor Corporation ’s ( TM ) shares remained stable at the close of session on Dec 24, after the company reported global production of 9.5 million vehicles for the first eleven months of 2014, up 1.4% year over year. Toyota’s total worldwide production fell 6.6% year over year to 830,106 units in Nov 2014. While production in Japan declined 5.7% to 331,319 units, production outside Japan went down 7.2% to 498,787 units. […]

Stock Analysts

Cerus Corporation Reports Phase II Red Blood Cells Data

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight on the commercial potential of the candidate once it is successfully developed and commercialized. […]

Stock Analysts

BP to Invest About $800 Million in Oilfield Deal with Rosneft

UK energy-giant BP plc ’s ( BP ) share prices increased marginally following the news that the company is close to buying a stake in an oilfield in East Siberia from state-owned giant Rosneft. According to a report, BP is close to paying about $800 million to acquire a stake in a Russian oil field that is likely to further strengthen the company’s relationship with Rosneft. BP refused to disclose any details. […]

Stock Analysts

Avery Hits 52-Week High on Q3 Strength & Positive Outlook

Shares of Avery Dennison Corporation ( AVY ) scaled a new 52-week high of $52.83 on Dec 26 and eventually closed at $52.62. The stock price appreciation came on the back of strong third-quarter results, expected synergies from expansion in emerging markets, introduction of innovative products, savings from the European restructuring and positive long-term outlook. This Pasadena, CA-based manufacturer of pressure-sensitive materials has a market cap of $4.8 billion. […]